Latest news

Our press releases and latest news

Here you will always find the latest news about Cannamedical® Pharma.



Cologne, June 12 2019 – Cannamedical® Pharma GmbH (Cannamedical), the leading German independent cannabis importer, signed three new supply agreements with Canadian producers of medical cannabis last month and is starting the process of EU-GMP Certification with three more Canadian partner companies. Cannamedical has already worked with two of the eight certified companies in Canada and contributed significantly to the success in receiving accreditation. The new agreements will enable Cannamedical to access twice as much medical cannabis, reaching 40,000 kilograms, which will be imported into Germany within the next five years. With these additional international partners, Cannamedical is also strengthening its global network with leading companies in the medical cannabis industry and is well positioned to meet the growing demands of the market.

“As the only German cannabis importer in the market with own-brand products, it is to our strategic advantage to have access to independent suppliers from all over the world to meet the growing demand in Germany”, says David Henn, founder and CEO of Cannamedical. “In addition to two cannabis flower producers, we will also certify a cannabis extract producer for the first time.”

All Cannamedical’s production partners are required to meet the world’s highest pharmaceutical quality standards, the so-called GMP (Good Manufacturing Practice) guidelines, as well as Cannamedical’s own high standards of quality and safety for a successful and sustainable collaboration. Cannamedical supports its partners in the GMP certification process, ensuring that all products meet the necessary and desired criteria.

At the beginning of June 2019, Cannamedical announced the immediate launch of medical cannabis flowers under its own brand. With this new product portfolio, Cannamedical can provide complete transparency and is creating a new therapy standard. The range comprises twelve products with exclusively homogeneous Indica, Sativa, Hybrid and CBD-rich flowers, in three strength categories: light, medium and forte.

The first two of the total of twelve GMP-compliant and pure Cannamedical varieties, CANNAMEDICAL INDICA and CANNAMEDICAL HYBRID forte, became available at pharmacies in Germany at the beginning of June 2019, following intensive quality controls.

Photo David Henn, CEO Cannamedical Pharma GmbH under:

Press contact

Sandra Grußbach
Phone: +49 221 999 852 51

About Cannamedical Pharma GmbH

We at Cannamedical Pharma GmbH are committed to helping doctors, medical specialists and pharmacists to improve their patients’ quality of life. The top-class products by Cannamedical concentrate on helping people with chronic illnesses to lead the best possible life with medicinal cannabis. To this end, we import and process only high-quality medicinal cannabis products and supply them to around 2,500 pharmacies and clinical facilities.
As well as the provision of top-class medicinal cannabis products, our focus is on training within the ecosystem of medical professionals, and sector-leading customer service. Our production partners worldwide must comply with the highest pharmaceutical quality standards – the so-called GMP guidelines (Good Manufacturing Practice). With its quality management, Cannamedical guarantees the highest product standards. We ourselves are GDP-certified (Good Distribution Practice), in other words, our entire supply chain is guaranteed, from the agricultural environment to the pharmacy. Cannamedical Pharma GmbH was founded in 2016 and has around 50 employees in Cologne. In addition, Cannamedical operates subsidiaries in Canada and the UK.
For more information, visit

We’re here to help

Contact us

Enjoy the benefits of our 360-degree all-round service.


Mo. – Fr. 8am-6pm
+49 221 999 96 – 0



We are member of the DGS, BPC and VCI


Logo VCA Deutschland apotheke ev

Follow us

Social media

We are active on the
following platforms.

We are committed to research and development in Germany.


Ihr Warenkorb
Let’s Talk About Cannabis!


Rundum-Blick auf die Cannabis-Legalisierung mit Gästen aus Politik, Kultur, Medizin und allen Teilen der Gesellschaft.

Ist die deutsche Gesellschaft bereit für die Legalisierung von Cannabis? Noch gibt es viele Fragen – die Antworten geben wir hier im Podcast. Let’s Talk About Cannabis: DER Podcast Deutschlands, der Cannabis in die Legalität begleitet.



Extract Study by Cannamedical about Pain Ease



Wissen schafft Gesundheit. Leisten Sie Ihren Beitrag zur Forschung und Weiterentwicklung der evidenzbasierten Cannabis-Medizin und seien Sie Teil der Zukunft, an der wir gemeinsam arbeiten.

Understanding patients needs. Because health is more than pain relief.




Jetzt neu: Entdecken Sie die Innovation des Jahres!

  • Vollumfängliches Wirkspektrum ✔️
  • Konstante Wirkstoffkonzentration ✔️
  • Einfache und exakte Dosierung ✔️
  • Reduzierte Therapiekosten ✔️

Möchten Sie mehr erfahren? Ärzte und Apotheker können Sie zu unserem neuen Produkt beraten!

Abbildung entspricht nicht dem Original.

Hotline für Ärzte
0221 999 96 – 160

Hotline für Apotheker
0221 999 96 – 125

Beratung, wann immer es Ihnen passt: Einfach Termin auswählen und wir rufen Sie zu der von Ihnen gewünschten Zeit an!

Unser Expertenteam steht Ihnen von Mo.–Fr. zwischen 8 und 18 Uhr zur Verfügung.

"*" indicates required fields


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bitte loggen Sie sich ein


Die Teilnahme an unseren exklusiven CannAcademy-Modulen ist ausschließlich medizinischen und pharmazeutischen Fachpersonen vorbehalten. Sie können sich sowohl mit Ihrem Cannamedical-Account als auch mit Ihren DocCheck-Login-Daten verifizieren.


Bitte loggen Sie sich mit Ihrem Cannamedical-Account ein.


Alternativ können Sie sich auch mit Ihrem DocCheck-Zugang einloggen.